Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
QIAGEN said U.S. laboratories now have access to its complete QIAstat-Dx bloodstream infection portfolio after FDA clearance of a new gram-negative bacteria detection panel. The panel identifies 13 bacterial targets and 18 antibiotic resistance markers in about one hour.
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that U.S. laboratories now have access to the complete QIAstat-Dx bloodstream infection portfolio following clearance of a new panel by the U.S. Food and Drug Administration (FDA).The new panel detects gram-negative bacteria an…